Evotec’s Post

We're excited to share a new testimonial from Barbara Tevelev, Manager Regulatory CMC Biologics at Pfizer highlighting how Solvias's Targeted Locus Amplification (TLA) technology has been instrumental in advancing their CLD development strategy. Learn more about how Solvias is helping companies like Pfizer achieve breakthrough clarity in cell line development. Download a full clonality case study and understand how we can help bring your innovation to its destination: 🔗 https://lnkd.in/eaGFWyrF #CustomerTestimonial #CellLineDevelopment #TLAtechnology #celltherapies #genetherapies #cgt #atmp #GenotypicCharacterization

Attending New Horizons in Biologics & Bioprocessing? Let's discuss your development & manufacturing challenges and how our science-first approach can be leveraged to propel your process to market. 👉https://ow.ly/qnLW50RNQml

While industry demands grow, biomanufacturing capacity expansion must be accompanied by enhanced technologies and capabilities to meet the evolving needs of complex molecules. The latest whitepaper highlights Samsung Biologics' key competitive advantages that a reliable CDMO possesses to enable the highest quality and accelerate success. https://lnkd.in/d7MC_rPT #SamsungBiologics #CDMO #manufacturing 

Abzena expands analytical capabilities to include GMP cell-based potency testing across US & UK sites Abzena, a leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has announced the expansion of their early and late phase analytical capabilities to now include GMP cell-based potency assays at their Cambridge, UK and San Diego, CA development and manufacturing facilities. The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster Full article on the SelectScience® website, link below: https://lnkd.in/epKwVsBD

ATCC plays a vital role in safeguarding bioproduction by providing high-quality reference materials essential for comprehensive testing strategies. In this Bioprocess International article our own Leka Papazisi, PhD and Fang Tian, PhD discuss how ATCC’s trusted solutions support the development of reliable analytic processes to ensure the safety and efficacy of biologics. #Bioproduction #Biopharma #QualityControl #ATCC Read the article: https://ow.ly/X0Vi50TSzPy

Establishing an effective chemistry, manufacturing, and control (CMC) strategy is critical to ensure the safety and quality of drug products. In this article, our analytical scientists discuss how we develop tailored strategies to support the development of next-generation biologics. Read more: https://lnkd.in/gtBfz_Yr #SamsungBiologics #cdmo #CMC #drugdevelopment 

Attending New Horizons in Biologics & Bioprocessing May 28? Let's discuss your development & manufacturing challenges and how our science-first approach can be leveraged to propel your process to market. 👉https://ow.ly/qnLW50RNQml

Biosimilars are safe and effective treatment options that: ✅ Are made with the same types of sources as original biologics ✅ Provide the same treatment risks and benefits ➡️ Click and view a helpful infographic to learn more: https://bit.ly/3K8TP9t

How Fully Connected Continuous Manufacturing lowers biologics cost per gram Turn your videos into live streams with Restream https://restre.am/ANIm

Discover tips to help efficiently scale biologics from research to clinical and commercial manufacturing at our virtual roundtable on January 22. Learn insights from industry experts about tech transfer, regulatory compliance, raw materials, supply chain management, and more—register now to get your questions answered LIVE! 👉 https://lnkd.in/e6cVHTFH #TechTransfer #RegulatoryCompliance #QualitySystems #SupplyChainManagement #Biologics #ThermoFisherScientific #AvidBioservices